Athersys/ US04744L2051 /
2023-10-17 10:00:00 PM | Chg. - | Volume | Bid1:59:29 AM | Ask1:59:58 AM | High | Low |
---|---|---|---|---|---|---|
0.1018USD | - | 95.27 mill. Turnover: 4.73 mill. |
0.0600Bid Size: 4,700 | 0.0610Ask Size: 100 | 0.1348 | 0.0982 |
GlobeNewswire
01-08
XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of t...
GlobeNewswire
2023-12-26
Delisting of Securities of SmileDirectClub, Inc.; Bellerophon Therapeutics, Inc.; Elys Game Technolo...
GlobeNewswire
2020-10-21
The Alliance for Regenerative Medicine Announces Election of 2021 Officers, Executive Committee, and...
GlobeNewswire
2019-11-14
Healios Receives Notification of Orphan Designation for Acute Respiratory Distress Syndrome Clinica...
GlobeNewswire
2019-10-02
The Alliance for Regenerative Medicine Announces Election of 2020 ARM Officers, Executive Committee,...
GlobeNewswire
2019-09-12
2019 Report on Stem Cell Therapy: Market Anticipates a CAGR of 28% Over 2019-2029
GlobeNewswire
2019-08-15
Global Stem Cell & Regenerative Therapy Market 2018-2024: A Research Outlook
GlobeNewswire
2019-07-24
The Alliance for Regenerative Medicine Releases List of Presenting Companies at the 2019 Cell & Gene...
GlobeNewswire
2019-07-02
Global $25.4 Bn Tissue Engineering (Technologies and Therapeutic) Markets, 2015-2018 & 2019-2024: Or...
GlobeNewswire
2019-05-28
Athersys to Participate in four Events at the International Society of Cell and Gene Therapy Confere...
GlobeNewswire
2019-05-20
Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thora...
GlobeNewswire
2019-05-14
Athersys Announces Fast Track Designation From FDA for MultiStem® Program for Acute Respiratory Dist...
GlobeNewswire
2019-05-03
Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026